Biosimilar Antibodies
| Cat.No. | Product Name | Information | Isotype |
|---|---|---|---|
| A2864 | Perakizumab (Anti-CTLA-8 / IL-17a) | Perakizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG1κ monoclonal antibody against interleukin-17A (IL-17A). MW: 145.8 KD. | Human IgG1 |
| A3120 | Obexelimab (Anti-CD19) | Obexelimab (Anti-CD19) is a humanized antibody targeting CD19. It can be used in research of autoimmune diseases and rheumatoid arthritis (RA). MW :147.24 KD. | Human IgG1 |
| A2609 | Clazakizumab (Anti-IL-6 / IFNb2) | Clazakizumab (Anti-IL-6 / IFNb2) is a monoclonal antibody targeting the IL-6 (interleukin-6). It inhibits the cytokine response to SARS-CoV-2 in COVID-19 and can be used for the research of psoriatic arthritis (PsA) and renal antibody-mediated rejection. MW :145.24 KD. | Human IgG1 |
| A2610 | Vobarilizumab (Anti-IL-6Ra / CD126) | Vobarilizumab (Anti-IL-6Ra / CD126) is a monoclonal antibody targeting IL-6R. It can be used in the research of inflammatory autoimmune diseases, such as rheumatoid arthritis. MW: 78.2 KD. | Human IgG1 |
| A2866 | Vunakizumab (Anti-CTLA-8 / IL-17a) | Vunakizumab (Anti-CTLA-8 / IL-17a) is a recombinant human IgGκ monoclonal antibody that targets interleukin-17A (IL-17A) and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis. MW: 146.28. | Human IgG1 |
| A3122 | Pritoxaximab (Anti-Shiga toxin (E.coli)) | Pritoxaximab (Anti-Shiga toxin (E.coli)) is a human chimeric IgG1(kappa) antibody that targets Shiga toxin 1 and Shiga toxin 2, produced by E. coli. It can be used in the treatment of haemolytic-uraemic syndrome (HUS). MW: 145.88 KD. | Human IgG1 |
| A2611 | Oleclumab (Anti-NT5E / CD73) | Oleclumab (Anti-NT5E / CD73) is a human IgG1λ monoclonal antibody targeting the CD73 function. It has an anti-tumour activity and can be used in treatment of advanced colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), mutant non-small-cell lung cancer (NSCLC). MW :143.14 KD. | Human IgG1 |
| A2867 | Fontolizumab (Anti-IFNg) | Fontolizumab (anti-IFNg) is a humanized monoclonal antibody directed against interferon-gamma (IFN-g) with immunomodulatory activity. MW: 144.8. | Human IgG1 |
| A3123 | Setoxaximab (Anti-Shiga toxin (E.coli)) | Setoxaximab (Anti-Shiga toxin (E.coli)) is a mouse chimeric IgG1(kappa) antibody that targets Shiga toxin 1 and Shiga toxin 2, produced by E. coli. It can be used in the treatment of haemolytic-uraemic syndrome (HUS). MW: 147.08 KD. | Human IgG1 |
| A2612 | Anti-PDGFB (MOR-8457) | Anti-PDGFB (MOR-8457) is a monoclonal antibody targeting PDGF-BB. It can be used in research of liver fibrosis in mice. MW :143.56 KD. | Human IgG1 |
| A2868 | Anti-CXCL10 / IP-10 (NI-0801) | Anti-CXCL10 / IP-10 (NI-0801) is a fully human monoclonal antibody against chemokine (C-X-C motif) ligand 10 (CXCL10). It has the potential to treat primary biliary cholangitis. MW: 146.08. | Human IgG1 |
| A3124 | Anti-HBsAg (OST 577) | Anti-HBsAg (OST 577) is monoclonal antibody targeting HBV surface antigen (HBsAg). It has the potential for chronic hepatitis B research. MW :144.6 KD. | Human IgG1 |
| A2613 | Anti-B7-H1 / PD-L1 / CD274 (MDX-1105) | Anti-B7-H1 / PD-L1 / CD274 (MDX-1105) is a fully humanised monoclonal antibody targeting B7-H1. It is used in research of advanced melanoma, non-small cell lung carcinoma, renal cell carcinoma, and ovarian cancer. MW: 150 KD. | Human IgG4SP |
| A3125 | Foravirumab (Anti-Rabies virus GP) | Foravirumab (Anti-Rabies virus GP) is a monoclonal antibody targeting rabies virus glycoprotein antigenic site III. It is suitable in treatment of rabies postexposure prophylaxis. MW :144.44 KD. | Human IgG1 |
| A2614 | Anti-PMEL (Genentech anti-PMEL17) | Anti-PMEL (Genentech anti-PMEL17) is a monoclonal antibody targeting human PMEL protein. It is used as a target for antibody drug conjugate (ADC) therapy in melanoma. MW :145.54 KD. | Human IgG1 |
| A3126 | Rafivirumab (Anti-Rabies virus GP) | Rafivirumab (Anti-Rabies virus GP) is a monoclonal antibody targeting rabies virus for the prophylaxis of rabies can be used for research of cocktails. MW: 145.9 KD. | Human IgG1 |
| A2615 | Anti-PMEL | Anti-PMEL is a monoclonal antibody targeting human PMEL protein. It is used as a target for antibody drug conjugate (ADC) therapy in melanoma. MW: 145.38 KD. | Human IgG1 |
| A2871 | Foralumab (Anti-CD3e) | Foralumab (Anti-CD3e) is a monoclonal antibody directed against cluster of differentiation 3 (CD3) epsilon with immunomodulatory activity. MW: 145.56 KD. | Human IgG1 |
| A3127 | Motavizumab (Anti-RSV-F) | Motavizumab (Anti-RSV-F) is a monoclonal antibody targeting human RSV (respiratory syncytial virus). It can be used in respiratory syncytial virus infection in high-risk infants research. MW: 145.32 KD. | Human IgG1 |
| A2616 | Inclacumab (Anti-P-Selectin / CD62p) | Inclacumab (Anti-P-Selectin / CD62p) is a humanized monoclonal IgG4 antibody selectively targets P-selectin. It reduces cell adhesion showing potential for prevention of sickle cell disease (SCD). MW :150 KD. | Human IgG4SP |
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.